$1.80
▼ -2.2% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market
Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
HIND earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.5% on average; after the most recent report on May 12, 2026 it moved +0.5%. The share price of $1.80 sits near its 52-week low.
Overview
52-week range
$1.75
$6.56
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-4.0%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.10 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.15 | — | — | -100.8% | +0.5% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-3.12 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-2.25 | — | — | — | — | earnings |
| Tue May 20, 2025 | Mar/2025 | $18.98 | — | — | — | -8.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1419.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-91.56 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-135.37 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-59.36 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.08 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.56 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26,955 | $31,591 | — | $34,627 | $49,954 | $198,581 | — | $84,526 |
| Cost of revenue | $15,297 | $14,946 | — | $16,577 | $25,719 | $44,162 | — | $47,441 |
| Gross profit | $11,658 | $16,645 | — | $18,050 | $24,235 | $154,419 | — | $37,085 |
| Operating income | $-862,566 | $-1M | — | $-9M | $-324,189 | $-198,998 | — | $-280,978 |
| Net income | $-685,556 | $-985,521 | — | $-8M | $-308,760 | $-293,974 | — | $-547,772 |
| EPS (diluted) | $-0.10 | $-0.15 | — | $-3.12 | $-799.90 | $-761.59 | — | $-1419.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8M | $9M | $5M | $6M | — | $3M | $101,904 | $743,000 |
| Inventory | — | — | — | — | $3M | $3M | $2M | $3M |
| Total current assets | $8M | $9M | $5M | $6M | — | $6M | $302,046 | $5M |
| Total assets | $9M | $10M | $6M | $7M | — | $1M | $1M | $1M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $2M | $3M | $3M | — | $5M | $6M | $4M |
| Total equity | $7M | $8M | $4M | $3M | $-5M | $-5M | $-4M | $-4M |
Implied volatility — last 90 days
No IV snapshots yet for HIND.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
HIND earnings FAQ
How does HIND stock usually react to earnings?
Across the last 2 reports the average next-day move was ±4.5%, up 1 times and down 1 times.